Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Mcap of 9 most valued firms jumps ₹2.15 trn, Airtel biggest winner
The combined market valuation of nine of the top-10 most valued firms jumped by Rs 2.15 lakh crore last week, with Bharti Airtel emerging as the biggest winner, in line with improving global risk sentiment. Last week, the BSE benchmark Sensex jumped 1,274.95 points, or 1.68 per cent. "Indian equity markets extended their recovery during the week, supported by easing geopolitical concerns, softer crude oil prices, and improving global risk sentiment. Although negotiations remain ongoing and the agreement is yet to be fully implemented, the reduction in geopolitical uncertainty has significantly improved market sentiment," Ponmudi R, CEO - Enrich Money, an online trading and wealth tech firm, said. The market valuation of Bharti Airtel surged by Rs 52,432.67 crore to Rs 11,62,963.30 crore, the most among the top-10 firms. Life Insurance Corporation of India (LIC) added Rs 51,675.23 crore, taking its valuation to Rs 5,56,726.30 crore. The valuation of Bajaj Finance soared by Rs 26,55
Analysts project up to 17% upside in healthcare stocks trading at new highs
Apollo Hospitals, Aster DM Healthcare, Sai Life Sciences have rallied up to 27% thus far in FY27; technical analysts remain bullish on these stocks given the favourable chart set-up.
7 most valued firms' mcap eroded ₹1.25 trn last week, RIL took biggest hit
The combined market valuation of seven of the top-10 most-valued firms eroded by Rs 1.25 lakh crore last week, with Reliance Industries taking the biggest hit, in-line with a bearish trend in equities. Last week, the BSE benchmark Sensex declined 532.4 points, or 0.71 per cent, and the NSE Nifty dipped 181.05 points, or 0.76 per cent. "Persistent FII selling remained the key drag on market sentiment despite supportive developments such as cooling crude oil prices and a recovery in the rupee against the US dollar. Concerns regarding the pace of monsoon advancement also weighed on investor confidence," Santosh Meena, Head of Research at Swastika Investmart Ltd, said. From the top-10 pack, Reliance Industries, Bharti Airtel, Tata Consultancy Services (TCS), Bajaj Finance, Larsen & Toubro, Life Insurance Corporation of India (LIC) and Hindustan Unilever faced erosion from their valuation, while HDFC Bank, ICICI Bank, and State Bank of India were the gainers. The market valuation of ...
Hospitals warn Central Government Health Scheme reimbursement cap may hurt cancer treatment
A major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement cap on life-saving immunotherapy drugs is creating financial strain for hospitals. This policy threatens patient access to essential treatments. The association has identified nine specific drugs that are now out of reach for many beneficiaries.
A strange world: Nithin Kamath says hospitals saving lives are valued less than brokerages
Zerodha CEO Nithin Kamath highlighted the valuation gap between hospitals and brokerages, noting that life-saving institutions like Narayana Health are valued far less than trading platforms, despite their societal impact.
What stock market values more? Nithin Kamath of Zerodha flags a paradox investors can’t ignore
Zerodha's Nithin Kamath raises concerns about market valuations, noting that financial firms often outpace essential healthcare providers like Narayana Hospitals. He emphasizes the oddity of valuing businesses closer to profit more highly than those providing critical life-saving services.
Buy Jupiter Hospitals; target of Rs 1560 Anand Rathi
Anand Rathi is bullish on Jupiter Hospitals recommended buy rating on the stock with a target price of Rs 1560 in its research report dated May 19, 2026.
Trade Spotlight: How should you trade Narayana Hrudayalaya, HDFC Life, Apollo Hospitals, Eternal, Laurus Labs, Max Healthcare, and others on May 12?
Consolidation is likely to continue in the market. Below are some short-term trading ideas to consider.
Buy Jupiter Life Line Hospitals; target of Rs 1600: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Jupiter Life Line Hospitals has recommended buy rating on the stock with a target price of Rs 1600 in its research report dated March 10, 2026.
Closing Bell: Market fails to hold gains, end lower amid late selling
Biggest Nifty losers were HDFC Bank, ONGC, HDFC Life, Titan Company, Apollo Hospitals, while gainers included Hindalco Industries, Trent, Adani Enterprises, Adani Ports and Eternal. Among sectors, IT, capital goods and metal indices gained 1% each, while auto, bank, oil & gas ended lower. The Nifty midcap index rose 0.6 percent and smallcap index added nearly 1 percent.
Taking Stock: Markets extend losses; Nifty slips below 24,200, Sensex declines 852 pts
Biggest Nifty losers were Trent, M&M, Shriram Finance, SBI Life Insurance, Tech Mahindra, while gainers included Dr Reddy's Labs, Cipla, Jio Financial, Adani Enterprises, Apollo Hospitals.
Closing Bell: Nifty below 25,200, Sensex tanks 961 pts; realty, metal, FMCG top drag
Nifty Midcap and smallcap indices down 1% each. Dr Reddy's Labs, Bharti Airtel, M&M, HDFC Life, Sun Pharma were among the top drags on the Nifty, while gainers were Trent, HCL Tech, Infosys, Apollo Hospitals. Among sectors, auto, bank, FMCG, metal, realty, telecom shed 1-2%, while IT, media, consumer durables ended in the green.